Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00322634 · ClinicalTrials.gov registry record
Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
A clinical trial of Cancer, sponsored by New Mexico Cancer Research Alliance.
- Completed
- Registry status
- 25
- Enrollment target
- 5
- Study locations
NCT00322634 is a study of Cancer that has completed, run by New Mexico Cancer Research Alliance. The registered enrollment target is 25 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT00322634, a study of Cancer, has completed, sponsored by New Mexico Cancer Research Alliance.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 5
- Study locations
Study Summary
The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
Conditions Studied
Study Locations (5)
New Mexico
- Hematology Oncology Associates - Albuquerque
- Radiation Oncology Associates - Albuquerque
- University of New Mexico - Albuquerque
- New Mexico Cancer Care Associates - Santa Fe
- St. Vincent Regional Medical Center - Santa Fe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-02 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00322634
The ClinicalTrials.gov registry entry for NCT00322634 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00322634 reports 5 study locations spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT00322634 about?
NCT00322634 is a clinical study titled "Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors". The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
What is the current status of trial NCT00322634?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2006-02. Estimated completion is 2011-07.
What conditions does trial NCT00322634 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT00322634?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00322634 being conducted?
This trial has 5 study locations across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.